Search
Close this search box.

September 5, 2023

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb’s long-standing expertise in immune-mediated diseases Zenas will receive a $50 million up-front cash payment and an equity investment from Bristol Myers

Reading more

Three Killed In Pakistan’s Navy Helicopter Crash

Three personnel of the Pakistani Navy were killed, in a helicopter crash, in Pakistan’s south-western Balochistan province yesterday, the navy said in a statement.The helicopter was on its routine training sortie, when it apparently met a technical fau…

Reading more

Search Keywords

Search